OVERGAARD GENETICS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  3.7% 2.7% 17.4% 1.8% 5.1%  
Credit score (0-100)  53 60 8 71 42  
Credit rating  BBB BBB BB A BBB  
Credit limit (kDKK)  0.0 -0.0 -0.0 -11.3 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  17,157 8,941 -7,248 5,060 6,278  
EBITDA  13,621 -529 -11,839 3,839 1,645  
EBIT  13,451 3,843 -12,007 1,337 2,085  
Pre-tax profit (PTP)  11,524.7 2,572.9 -13,303.9 -402.7 -1,785.4  
Net earnings  12,927.7 1,797.9 -12,709.0 932.3 -4,865.3  
Pre-tax profit without non-rec. items  11,525 2,573 -13,304 -403 -1,785  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  6,166 6,370 4,332 6,450 5,236  
Shareholders equity total  -8,992 -7,194 -19,903 -18,971 -23,836  
Interest-bearing liabilities  36,067 26,522 31,414 37,935 39,297  
Balance sheet total (assets)  30,302 21,899 14,777 21,450 19,921  

Net Debt  36,062 26,516 31,405 37,927 39,288  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  17,157 8,941 -7,248 5,060 6,278  
Gross profit growth  643.5% -47.9% 0.0% 0.0% 24.1%  
Employees  0 0 0 0 12  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  30,302 21,899 14,777 21,450 19,921  
Balance sheet change%  41.5% -27.7% -32.5% 45.2% -7.1%  
Added value  13,620.8 4,114.4 -11,723.2 1,620.7 2,351.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  1,558 -67 -2,322 1,834 -1,481  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 -1.0 1.0 2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  78.4% 43.0% 165.7% 26.4% 33.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  33.1% 12.3% -37.0% 5.2% 5.4%  
ROI %  37.1% 13.4% -40.0% 5.4% 5.7%  
ROE %  50.0% 6.9% -69.3% 5.1% -23.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -22.9% -24.7% -57.4% -46.9% -54.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  264.8% -5,016.9% -265.3% 987.9% 2,388.9%  
Gearing %  -401.1% -368.7% -157.8% -200.0% -164.9%  
Net interest  0 0 0 0 0  
Financing costs %  5.9% 5.2% 5.2% 6.8% 10.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.5 0.5 0.6 0.3 0.0  
Current Ratio  1.8 2.0 1.1 0.9 0.7  
Cash and cash equivalent  5.4 5.8 8.5 8.2 8.4  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  8,235.5 5,758.0 347.1 -818.2 -5,265.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 196  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 137  
EBIT / employee  0 0 0 0 174  
Net earnings / employee  0 0 0 0 -405